|Articles|December 27, 2021
FDA approves HIV pre-exposure preventive injection
Author(s)Keith A. Reynolds
Apretude is approved for use in at-risk adults and adolescents to reduce the risk of sexually acquired HIV.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
20-year data show shifting causes of pregnancy-related death
2
FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues
3
FDA-cleared, post-intercourse vaginal health device launches
4
HCV testing and postpartum treatment gaps persist among pregnant women with opioid use disorder
5